DESIGN, SYNTHESIS, DOCKING STUDIES AND BIOLOGICAL EVALUATION OF 2-PHENYL-3-(SUBSTITUTED BENZO[d] THIAZOL-2-YLAMINO)-QUINAZOLINE-4(3H)-ONE DERIVATIVES AS ANTIMICROBIAL AGENTS

Authors

  • Pooja Pisal PDEA'S SGRS COLLEGE OF PHAMACY, SASWAD
  • Meenakshi Deodhar Department of Pharmaceutical Chemistry, PDEA’s Seth Govind Raghunath Sable College of Pharmacy, Saswad, Pune 412301, India
  • Amol Kale PDEA'S SGRS COLLEGE OF PHAMACY, SASWAD
  • Ganesh Nigade PDEA’s Seth Govind Raghunath Sable College of Pharmacy, Saswad, Pune 412301, India
  • Smita Pawar PDEA'S SGRS COLLEGE OF PHAMACY, SASWAD

DOI:

https://doi.org/10.22159/ijpps.2018v10i10.28480

Keywords:

Benzothiazole, Benzoxazine, Quinazoline, Antimicrobials

Abstract

Objective: A new series 2-phenyl-3-(substituted benzo[d] thiazol-2-ylamino)-quinazoline-4(3H)-one was prepared by the fusion method by reacting 2-phenyl benzoxazine with 2-hydrazino benzothiazole and it was evaluated for their antimicrobial activity against gram positive, gram negative bacteria and fungi.

Methods: Titled compounds were synthesized by fusion reactions. These compounds were evaluated by in vitro antibacterial and antifungal activity using the minimum inhibitory concentration and zone of inhibition methods. The synthesized compounds were characterized with the help of infrared, NMR and mass spectral studies. The benzothiazole moiety and the quinazoline ring have previously shown DNA gyrase inhibition and target related antibacterial activity. Thus, molecular docking studies of synthesized compounds were carried out (PDB: 3G75) to study the possible interaction of compounds with the target. The batch grid docking was performed to determine the probable.

Results: These compounds showed significant activity against gram positive and gram negative bacteria as well against the fungi. The compound A5 was found to be active against B. subtilis, P aeruginosa and C. albican at 12.5 µg/ml MIC. The compound A3 was found to be active against all microbial strains selected at 25 and 12.5 µg/ml MIC.

Conclusion: Though the relationship between the activities shown by these compounds in, the antimicrobial study is still to be established, the docking studies conducted found to be consistent with antimicrobial results. Thus the results indicate that the designed structure can be a potential lead as an antimicrobial agent.

Downloads

Download data is not yet available.

References

Oren I, Yalcin I, Senar E¸ Ucarturk N. Synthesis and structure-activity relationships of new antimicrobial active multisubstituted benzoxazole derivatives. Eur J Med Chem 2004;34:291–8.

Geofrey W, Bradshaw TD, Patrizia Diana, Angela S, Dong Fang Shi, Andrew D, et al. Antitumour benzothiazoles. Part10: the synthesis and antitumor activity of benzothiazole substituted quinol derivatives. Bioorg Med Chem Lett 2000;1:513-5.

Delmas F, Avellaneda A, Giorgio C, Robin M, Clercq E, David P, et al. Synthesis and antileishmanial activity of (1,3-benzothiazol-2-yl) amino-9-(10H)-acridinone derivatives. Eur J Med Chem 2004;1:685-90.

Bujdakovi H, Mfikovfi M. Antifungal activity of a new benzothiazole derivative against Candida in vitro and in vivo. Inter J Antimicrobial Agents 1994;4:303-8.

Raghvendra N, Niranjan M, Venkatesh P, Prashantha B, Sripathi M. Synthesis and biological activity of some substituted 2-phenyl-quinazolin-4ones. Asian J Res Chem 2005;17:57-65.

Kohli D, Riazh, Sharma M, Kumar A. Synthesis and antibacterial activity of quinazolinone derivatives. Int J Pharm Pharm Sci 2009;1:163-9.

Mohsen M, Yahia A, Khairy A, Wahid M, Samir Y. Synthesis of some 4-(3H)-quinazolinone-2-carboxaldehyde thiosemi-carbazones and their metal complexes and study on their anticonvulsant, analgesic, cytotoxic and antimicrobial activities. Eur J Med Chem 2010;45:3365-73.

Oblak, Simona M, Roman GG, Filipic J, Tomaz SO. In silico fragment-based discovery of indolin-2-one analogues as potent DNA gyrase inhibitors. Bioorg Med Chem Lett 2005;15:5207.

Shireesha B, Umasankar K, Srinivas S, Malla RV. Synthesis, antimicrobial evaluation, and docking studies of novel 4-substituted quinazoline derivatives as DNA-gyrase inhibitors. Arch Pharm Chem Life Sci 2010;10:570–6.

Busari K, Amnerkar N, Khedekar P, Kale M, Bhole R. Synthesis of in vitro antimicrobial activity of some 4-amino-N-(1,3-benzothiazol-2-yl) benzenesulfonamide derivatives. Asian J Res Chem 2008;2:53-7.

Rana A, Siddiqui N, Khan A, Haque S, Bhat M. N-{[(6-Substituted-1,3-benzothiazole-2-yl) amino]carbonothioyl}-2/4-substituted benzamides: Synthesis and pharmacological evaluation. Eur J Med Chem 2008;1:1114-22.

Basavaraja K, Somasekhar B, Shivakumar B. Synthesis of 2-[(1-phenyl) (aryl) azo] methyleneimino-6-chloro/fluoro-benzothiazoles and their antibacterial activity. Inter J Pharm Tech Res 2010;2:1139-43.

Alagarsamy V, Rajasolomon V, Vanikavitha G, Paluchamy V, Ravichandran M, Arnoldsujin A, et al. Synthesis, analgesic, antiinflammatory and antibacterial activities of some novel 2-phenyl-3-substituted quinazolin-4(3H)-ones. Biol Pharm Bull 2002;25:1432–5.

Ganguli S, Panigrahi M, Singh P, Shukla P. One-pot synthesis of novel quinazoline derivatives and their antimicrobial activity. Int J Pharm Pharm Sci 2012;4:434-40.

Published

01-10-2018

How to Cite

Pisal, P., M. Deodhar, A. Kale, G. Nigade, and S. Pawar. “DESIGN, SYNTHESIS, DOCKING STUDIES AND BIOLOGICAL EVALUATION OF 2-PHENYL-3-(SUBSTITUTED BENZO[d] THIAZOL-2-YLAMINO)-QUINAZOLINE-4(3H)-ONE DERIVATIVES AS ANTIMICROBIAL AGENTS”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 10, no. 10, Oct. 2018, pp. 57-61, doi:10.22159/ijpps.2018v10i10.28480.

Issue

Section

Original Article(s)